Previous research at Cardiff has established the important role of Bcl3 in metastatic progression of HER2- positive breast cancer within in vitro and in vivo models (Wakefield, A., et al.Cancer Res. 2013, 73, 745–755). This evidence concerns the gene ERBB2 and breast carcinoma.